Camille Moeckel, MD

Article

Pembrolizumab-Induced Bullous Pemphigoid: Navigating Diagnostic Challenges and Treatment Resistance

Author:: Camille Moeckel, MD

Publish date: June 30, 2026

Bullous pemphigoid (BP) is an autoimmune blistering disorder characterized by the development of tense subepidermal blisters and erosions primarily...